Vaccine manufacturer Virbac is making plans to increase the production of cat vaccines at its French plants to help UK practices manage the prospect of a shortfall in supply.

Vaccine manufacturer Virbac is making plans to increase the production of cat vaccines at its French plants to help UK practices manage the prospect of a shortfall in supply.

Virbac to increase the production of cat vaccines at its French plants, following warnings by other manufacturers of potential stock shortages.The move follows warnings that two significant cat vaccine brands are out of stock at wholesalers – a situation that reports suggest may remain an issue until the end of the year and, possibly, for as long as 6 months.

In response to this news, Virbac was keen to reassure UK practices that it will do its utmost to ensure continuity of supply during this period. However, the manufacturer is urging them to order as usual and not stockpile product, which could exacerbate the problem.

Simon Boulton, product manager for Virbac’s vaccine range, explained: “Our priority is to keep stock flowing to our existing customers. With this in mind, we’ve now ceased to supply wholesalers with our cat vaccines. Once wholesaler stocks have been depleted, we ask customers to contact us directly so that stock can be despatched to them from our own warehouse.

“By taking this step, we can manage our own stocks effectively and, while we’ll be putting our existing customers first, we also stand ready to help supply the rest of the veterinary sector during this period. As a primary manufacturer of vaccines, we’re well placed to react quickly to stock shortages and expect to have significantly increased supply by November.”

 

  • For further information, practices should contact their Virbac territory manager.
  • Direct orders to the company can be made by calling 01359 243243 and selecting Option 3 (Direct Orders).
View your activity >

Leave a Reply

Be the First to Comment!

Notify of
avatar

wpDiscuz